{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:52:35Z","timestamp":1789523555687,"version":"build-2803163510"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Glioblastoma (GBM) is the most common and fatal primary brain malignancy in adults, and therapeutic gains have been modest despite multimodal standard care. Immunotherapy offers a promising alternative, yet its performance in GBM is constrained by a profoundly immunosuppressive neuro-immune micro-environment, the physical and functional barriers of the blood\u2013brain interface, and adaptative resistance pathways. In this review we summarise recent progress in myeloid-reprogramming agents, immune-checkpoint modulation, adoptive cellular therapies and device-enabled delivery platforms that seek to revitalise anti-tumour surveillance within the central nervous system. We also discuss enduring challenges\u2014including intratumoural spatial heterogeneity, limited effector lymphocyte trafficking and the scarcity of robust predictive biomarkers\u2014that temper durable responses. By thoughtfully integrating immunologic approaches with radiotherapy, anti-angiogenic agents, metabolic modifiers and focussed-ultrasound-mediated blood\u2013brain-barrier disruption, emerging strategies aspire to enhance immune infiltration, bolster antigen presentation and overcome region-specific barriers. Our synthesis provides an appraisal of the evolving landscape of precision immunotherapy for GBM, offering perspective on future directions and avenues for clinical translation. We hope these insights will assist researchers and clinicians as they endeavour to develop more effective and individualised treatment regimens for patients confronted with this formidable disease.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1661327","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:22:32Z","timestamp":1757391752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting the neuroimmune axis in glioblastoma: emerging strategies for precision immunotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoling","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017 \u2013 2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro-oncology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00476","article-title":"Key clinical principles in the management of glioblastoma","volume":"19","author":"Kotecha","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1272546","article-title":"A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid","volume":"14","author":"Cao","year":"2023","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10312","DOI":"10.1038\/s41467-024-54569-4","article-title":"Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains mouse low-grade glioma growth","volume":"15","author":"Barakat","year":"2024","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s12672-024-01464-5","article-title":"The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential","volume":"15","author":"Xiong","year":"2024","journal-title":"Discov Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1403396","article-title":"Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors","volume":"12","author":"Fan","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"vdae202","DOI":"10.1093\/noajnl\/vdae202","article-title":"Phase 1b\/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma","volume":"6","author":"Mendez","year":"2024","journal-title":"Neuro-Oncol Adv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/brainsci12060700","article-title":"A novel classification model for lower-grade glioma patients based on pyroptosis-related genes","volume":"12","author":"Shen","year":"2022","journal-title":"Brain Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"vdad044","DOI":"10.1093\/noajnl\/vdad044","article-title":"Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma","volume":"5","author":"Sperring","year":"2023","journal-title":"Neuro-Oncol Adv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1038\/s41467-024-48326-w","article-title":"Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas","volume":"15","author":"Arrieta","year":"2024","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad216.022","article-title":"Phase 1b\/2 trial of ipilimumab, nivolumab, and ciforadenant (INC)(adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma","volume":"28","author":"Beckermann","year":"2023","journal-title":"Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0301223","DOI":"10.1371\/journal.pone.0301223","article-title":"Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor","volume":"19","author":"Wang","year":"2024","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.02.007","article-title":"Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics","volume":"177","author":"Wei","year":"2024","journal-title":"Acta Biomater"},{"key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41698-023-00413-9","article-title":"Radiomics for characterization of the glioma immune microenvironment","volume":"7","author":"Khalili","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02347-y","article-title":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1\/2 trial","volume":"29","author":"Nassiri","year":"2023","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.05.009","article-title":"Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma","volume":"40","author":"Ravi","year":"2022","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood\u2013brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10238-024-01454-5","article-title":"Integrative single-cell and bulk transcriptome analyses identify a distinct pro-tumor macrophage signature that has a major prognostic impact on glioblastomas","volume":"24","author":"Li","year":"2024","journal-title":"Clin Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1254232","article-title":"Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms","volume":"10","author":"Chi","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"20874","DOI":"10.1038\/s41598-023-48116-2","article-title":"Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma","volume":"13","author":"Batchu","year":"2023","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41698-025-00920-x","article-title":"Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy","volume":"9","author":"Zhao","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0913","article-title":"Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population","volume":"14","author":"Wang","year":"2024","journal-title":"Cancer Discov"},{"key":"B30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s43018-023-00706-9","article-title":"Intra-tumoral T cells in pediatric brain tumors display clonal expansion and effector properties","volume":"5","author":"Upadhye","year":"2024","journal-title":"Nat Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/or.2025.8921","article-title":"Prospects and applications of NK therapy in the treatment of gliomas","volume":"54","author":"Liu","year":"2025","journal-title":"Oncol Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e179854","DOI":"10.1172\/jci.insight.179854","article-title":"Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment","volume":"9","author":"Rosberg","year":"2024","journal-title":"JCI Insight"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-024-08579-3","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","author":"Barron","year":"2025","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/gad.351427.123","article-title":"Glioblastoma microenvironment\u2014from biology to therapy","volume":"38","author":"Read","year":"2024","journal-title":"Genes Dev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111963","article-title":"The aryl hydrocarbon receptor cell intrinsically promotes resident memory CD8+ T cell differentiation and function","volume":"42","author":"Dean","year":"2023","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-025-08147-z","article-title":"Loss of LAPTM4A inhibits M2 polarization of tumor-associated macrophages in glioblastoma, promoting immune activation and enhancing anti-PD1 therapy","volume":"8","author":"Geng","year":"2025","journal-title":"Commun Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","article-title":"Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression","volume":"15","author":"Khan","year":"2024","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e175033","DOI":"10.1172\/JCI175033","article-title":"STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma","volume":"134","author":"Najem","year":"2024","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1038\/s41467-024-48073-y","article-title":"TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in Malignant glioma: a randomized phase II Trial","volume":"15","author":"Everson","year":"2024","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf080","article-title":"Brain CD73 modulates interferon signaling to regulate glioblastoma invasion","volume":"7","author":"Kyritsi","year":"2025","journal-title":"Neuro-Oncol Adv"},{"key":"B42","doi-asserted-by":"publisher","first-page":"111550","DOI":"10.1016\/j.cellsig.2024.111550","article-title":"Proguanil inhibits proliferation and migration in glioblastoma development through targeting CSF1R receptor","volume":"127","author":"Ren","year":"2025","journal-title":"Cell Signalling"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0576","article-title":"Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia\/macrophages by treatment with GW2580","volume":"29","author":"Fermi","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1181467","article-title":"Uncovering the potential role of oxidative stress in the development of periodontitis and establishing a stable diagnostic model via combining single-cell and machine learning analysis","volume":"14","author":"Song","year":"2023","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41416-025-02977-8","article-title":"CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma","author":"Strassheimer","year":"2025","journal-title":"Br J Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","author":"Vitanza","year":"2025","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"noaf099","DOI":"10.1093\/neuonc\/noaf099","article-title":"Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade","author":"Hung","year":"2025","journal-title":"Neuro-Oncology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01293-y","article-title":"Cell-intrinsic metabolic phenotypes identified in patients with glioblastoma, using mass spectrometry imaging of 13C-labelled glucose metabolism","volume":"7","author":"Tsyben","year":"2025","journal-title":"Nat Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265959","article-title":"Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (\u2265 5 cm): a multicenter experience over a ten-year period","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"eade3559","DOI":"10.1126\/sciadv.ade3559","article-title":"TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Sci Adv"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1038\/s41467-025-59326-9","article-title":"CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/s41467-024-47185-9","article-title":"Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging","volume":"15","author":"Watson","year":"2024","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.08.012","article-title":"Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence","volume":"42","author":"Watson","year":"2024","journal-title":"Cancer Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9718","DOI":"10.1038\/s41467-024-54129-w","article-title":"Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRP\u03b3-derived CD47 blocker","volume":"15","author":"Martins","year":"2024","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.3390\/su15129355","article-title":"Evolutionary game analysis of artificial intelligence such as the generative pre-trained transformer in future education","volume":"15","author":"You","year":"2023","journal-title":"Sustainability"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: Current state, challenges, and future perspectives","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101238","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell Rep Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41419-024-06784-6","article-title":"CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178628","article-title":"Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma","volume":"134","author":"Liu","year":"2024","journal-title":"J Clin Invest"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-025-60074-z","article-title":"Glioma-neuronal circuit remodeling induces regional immunosuppression","volume":"16","author":"Nejo","year":"2025","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"216480","DOI":"10.1016\/j.canlet.2023.216480","article-title":"STING activation counters glioblastoma by vascular alteration and immune surveillance","volume":"579","author":"Joseph","year":"2023","journal-title":"Cancer Lett"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-023-43743-9","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S414926","article-title":"Construction and validation of TACE therapeutic efficacy by ALR score and nomogram: a large, multicenter study","author":"Li","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"B64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41540-024-00419-4","article-title":"Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies","volume":"10","author":"Mongeon","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e009449","DOI":"10.1136\/jitc-2024-009449","article-title":"Inhibitory Fc\u03b3 receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma","volume":"12","author":"Ku","year":"2024","journal-title":"J ImmunoTher Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16128","article-title":"Upregulation of HLA-II related to LAG-3+ CD4+ T cell infiltration is associated with patient outcome in human glioblastoma","volume":"115","author":"Guo","year":"2024","journal-title":"Cancer Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00598-9","article-title":"Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response","volume":"4","author":"Mei","year":"2023","journal-title":"Nat Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00262-024-03808-0","article-title":"Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model","volume":"73","author":"Tachi","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1371682","article-title":"Exploration of physical activity, sedentary behavior and insulin level among short sleepers","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.07.020","article-title":"Armored bicistronic CAR T cells with dominant-negative TGF-\u03b2 receptor II to overcome resistance in glioblastoma","volume":"32","author":"Li","year":"2024","journal-title":"Mol Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae126","article-title":"IL-13R\u03b12\/TGF-\u03b2 bispecific CAR-T cells counter TGF-\u03b2-mediated immune suppression and potentiate anti-tumor responses in glioblastoma","volume":"26","author":"Hou","year":"2024","journal-title":"Neuro-oncology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1661327\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:22:34Z","timestamp":1757391754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1661327\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2025.1661327"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1661327","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"article-number":"1661327"}}